Trial intelligence / Profile preview

Sedation Effects on Motor Networks in Brain Glioma

NCT03984240Completed

Sponsor
Beijing Tiantan Hospital
Start
Nov 2020
Primary completion
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of midazolam and dexmedetomidine in brain glioma (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Brain network connectivity at 2 hours. Started Nov 2020; status: completed.

02

Drugs

midazolamdexmedetomidine
03

Conditions

brain glioma

Beyond the preview

Go deeper on NCT03984240.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03984240.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call